Jonas Bergh

Jonas Bergh

UNVERIFIED PROFILE

Are you Jonas Bergh?   Register this Author

Register author
Jonas Bergh

Jonas Bergh

Publications by authors named "Jonas Bergh"

Are you Jonas Bergh?   Register this Author

100Publications

2082Reads

5Profile Views

Impairment of endoxifen formation in tamoxifen-treated premenopausal breast cancer patients carrying reduced-function CYP2D6 alleles.

Br J Clin Pharmacol 2020 Jul 26. Epub 2020 Jul 26.

Department of Laboratory Medicine, Clinical Pharmacology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcp.14500DOI Listing
July 2020

Chemotherapy use near the end-of-life in patients with metastatic breast cancer.

Breast Cancer Res Treat 2020 Jun 7;181(3):645-651. Epub 2020 May 7.

Department of Oncology/Pathology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-020-05663-wDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220858PMC
June 2020

A pan-cancer analysis of the frequency of DNA alterations across cell cycle activity levels.

Oncogene 2020 Jun 24. Epub 2020 Jun 24.

Department of Oncology and Pathology, Karolinska Institutet and University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41388-020-1367-4DOI Listing
June 2020

Outcome and presentation of heart failure in breast cancer patients: findings from a Swedish register-based study.

Eur Heart J Qual Care Clin Outcomes 2020 Apr;6(2):147-155

Department of Cardiology and Department of Health, Medicine and Caring Sciences, Norrkoping, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ehjqcco/qcz039DOI Listing
April 2020

Pembrolizumab for Early Triple-Negative Breast Cancer.

N Engl J Med 2020 02;382(9):810-821

From Barts Cancer Institute, Queen Mary University of London, London (P.S.); International Oncology Bureau Institute of Oncology, Quirón Group, Madrid, and Vall d'Hebron Institute of Oncology, Barcelona (J.C.) - both in Spain; Yale School of Medicine, Yale Cancer Center, New Haven, CT (L.P.); Cedars-Sinai Medical Center, Los Angeles (H.M.); Kliniken Essen-Mitte, Essen (S.K.), the Institute of Pathology, Philipps-University Marburg and University of Marburg, Marburg (C.D.), the Breast Center, Department of Obstetrics and Gynecology and Comprehensive Cancer Center Ludwig Maximilian University of Munich, University of Munich, Munich (N.H.), University Hospital Erlangen, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-European Metropolitan Region of Nuremberg, Erlangen (P.A.F.), and the Breast Cancer Center, Helios Klinikum Berlin-Buch, Berlin (M.U.) - all in Germany; the Department of Oncology-Pathology, Karolinska Institutet and Breast Cancer Center, Theme Cancer, Karolinska University Hospital, Solna, Sweden (J.B., T.F.); Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (Y.H.P.); Westmead Breast Cancer Institute, Westmead Hospital and the University of Sydney, Sydney (R.H.); Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan (M.T.); the Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal (F.C.); Merck, Kenilworth, NJ (L.J., V.K., J.Z., G.A.); the National Cancer Center Singapore, Duke-National University of Singapore Medical School, Singapore (R.D.); and Baylor University Medical Center, Texas Oncology and US Oncology, Dallas (J.O.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1910549DOI Listing
February 2020

Generation of in situ sequencing based OncoMaps to spatially resolve gene expression profiles of diagnostic and prognostic markers in breast cancer.

EBioMedicine 2019 Oct 13;48:212-223. Epub 2019 Sep 13.

Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2019.09.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838368PMC
October 2019

Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy.

Cancers (Basel) 2019 May 5;11(5). Epub 2019 May 5.

Department of Oncology - Pathology, Karolinska Institutet, Stockholm, 171 76, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11050628DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562626PMC
May 2019

High-intensity exercise during chemotherapy induces beneficial effects 12 months into breast cancer survivorship.

J Cancer Surviv 2019 04 25;13(2):244-256. Epub 2019 Mar 25.

Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11764-019-00747-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482129PMC
April 2019

RE: Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis.

J Natl Cancer Inst 2018 11;110(11):1280-1281

Department of Oncology-Pathology, Karolinska Institutet, Breast Cancer Group and Radiumhemmet, Cancer Theme, Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
https://academic.oup.com/jnci/article/110/11/1280/4956469
Publisher Site
http://dx.doi.org/10.1093/jnci/djy046DOI Listing
November 2018

Pharmacogenetic impact of docetaxel on neoadjuvant treatment of breast cancer patients.

Pharmacogenomics 2018 11 10;19(16):1259-1268. Epub 2018 Sep 10.

Department of Clinical Oncology, Karolinska University Hospital, SE171-76 Stockholm, Sweden.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/pgs-2018-0080
Publisher Site
http://dx.doi.org/10.2217/pgs-2018-0080DOI Listing
November 2018

Prognostic value of Ki67 analysed by cytology or histology in primary breast cancer.

J Clin Pathol 2018 Sep 27;71(9):787-794. Epub 2018 Mar 27.

Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jclinpath-2017-204976DOI Listing
September 2018

Time from breast cancer diagnosis to therapeutic surgery and breast cancer prognosis: A population-based cohort study.

Int J Cancer 2018 09 17;143(5):1093-1104. Epub 2018 Apr 17.

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, 171 77, Sweden.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.31411
Publisher Site
http://dx.doi.org/10.1002/ijc.31411DOI Listing
September 2018

Effect of CYP2C19 and CYP2D6 genotype on tamoxifen treatment outcome indicates endogenous and exogenous interplay.

Pharmacogenomics 2018 08 19;19(13):1027-1037. Epub 2018 Jul 19.

Department of Oncology & Pathology, Karolinska Institutet, SE171-76 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs-2018-0089DOI Listing
August 2018

Feasibility of reusing time-matched controls in an overlapping cohort.

Stat Methods Med Res 2018 06 21;27(6):1818-1829. Epub 2016 Sep 21.

1 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0962280216669744DOI Listing
June 2018

Do patients whose tumor achieved a pathological response relapse at specific sites? A substudy of the EORTC 10994/BIG-1-00 trial.

Breast Cancer Res Treat 2018 Jun 12;169(3):497-505. Epub 2018 Feb 12.

Department of Medical Oncology, Institut Bergonié Unicancer, Université de Bordeaux, INSERM U1218, INSERM CIC1401, 229 Cours de l'Argonne, 33000, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-4698-xDOI Listing
June 2018

Digital image analysis of Ki67 in hot spots is superior to both manual Ki67 and mitotic counts in breast cancer.

Histopathology 2018 May 14;72(6):974-989. Epub 2018 Feb 14.

Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13452DOI Listing
May 2018

Safety of fertility preservation in breast cancer patients in a register-based matched cohort study.

Breast Cancer Res Treat 2018 02 2;167(3):761-769. Epub 2017 Nov 2.

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4555-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807458PMC
February 2018

Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer Cohorts.

Clin Cancer Res 2017 Dec 29;23(24):7512-7520. Epub 2017 Sep 29.

Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet and University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-1535DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822691PMC
December 2017

Apropå! En välfungerande enhet.

Authors:
Jonas Bergh

Lakartidningen 2017 12 7;114. Epub 2017 Dec 7.

Karolinska Institutet - Onkologi-Patologi Stockholm, Sweden Karolinska Universitetssjukhuset - Onkologi Stockholm, Sweden.

View Article

Download full-text PDF

Source
December 2017

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.

N Engl J Med 2017 11;377(19):1836-1846

From the Medical Research Council Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford (H.P., R.G., J. Braybrooke, C.D., C.T., P.M., R.P.), and Royal Marsden Hospital and Institute of Cancer Research, London (M.D.) - both in the United Kingdom; Sunnybrook Health Sciences Centre and the University of Toronto, Toronto (K.I.P.); Karolinska Institutet and Karolinska University Hospital, Stockholm (J. Bergh); and the University of Michigan Comprehensive Cancer Center, Ann Arbor (D.F.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1701830DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734609PMC
November 2017

An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression.

Cancer Cell 2017 11;32(5):669-683.e5

Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge CB2 3EG, UK; Department of Cell and Molecular Biology, Karolinska Institute, 171 77 Stockholm, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2017.10.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691891PMC
November 2017

Breast cancer in young women and prognosis: How important are proliferation markers?

Eur J Cancer 2017 10 29;84:278-289. Epub 2017 Aug 29.

Karolinska Institutet, Department of Molecular Medicine and Surgery, Stockholm, Sweden; Department of Breast- and Endocrine Surgery, Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.07.044DOI Listing
October 2017

Dose intense, dose dense and tailored dose adjuvant chemotherapy for early breast cancer: an evolution of concepts.

Acta Oncol 2017 Sep 24;56(9):1143-1151. Epub 2017 May 24.

a Department of Oncology-Pathology , Karolinska Institutet and University Hospital , Stockholm , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0284186X.2017.1329593DOI Listing
September 2017

Tackling endocrine resistance in ER-positive HER2-negative advanced breast cancer: A tale of imprecision medicine.

Crit Rev Oncol Hematol 2017 Jun 7;114:91-101. Epub 2017 Apr 7.

Department of Oncology-Pathology, Karolinska Institutet and University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2017.04.002DOI Listing
June 2017

A prospective exploration of symptom burden clusters in women with breast cancer during chemotherapy treatment.

Support Care Cancer 2017 05 15;25(5):1423-1429. Epub 2016 Dec 15.

Department of Neurobiology, Care Science and Society, Division of Nursing, Karolinska Institutet, Huddinge, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-016-3527-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378737PMC
May 2017

Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials.

J Clin Oncol 2017 May 20;35(15):1641-1649. Epub 2017 Mar 20.

Carolyn Taylor, Frances K. Duane, David Dodwell, Richard Gray, Zhe Wang, Yaochen Wang, Richard Peto, and Paul McGale, University of Oxford, Oxford, United Kingdom; Candace Correa, Regional Cancer Center, Utica, NY; Marianne C. Aznar, Rigshospitalet, Copenhagen; Marianne Ewertz, Odense University Hospital, Odense, Denmark; Stewart J. Anderson, University of Pittsburgh, Pittsburgh, PA; Jonas Bergh, Karolinska Institutet and University Hospital, Stockholm, Sweden; Reshma Jagsi and Lori Pierce, University of Michigan, Ann Arbor MI; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, Toronto; Tim Whelan, Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada; and Sandra Swain, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.72.0722DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548226PMC
May 2017

Contrast-enhanced ultrasound (CEUS) in assessing early response among patients with invasive breast cancer undergoing neoadjuvant chemotherapy.

Acta Radiol 2017 Apr 28;58(4):394-402. Epub 2016 Jul 28.

5 Department of Oncology, Karolinska Institutet, Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0284185116658322DOI Listing
April 2017

Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: A population-based cohort study.

Cancer 2017 02 11;123(3):468-475. Epub 2016 Oct 11.

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30364DOI Listing
February 2017

[Chemotherapy and targeted drugs to reinforce each other].

Lakartidningen 2017 02 14;114. Epub 2017 Feb 14.

Karolinska Institutet - Onkologi-Patologi Stockholm, Sweden Karolinska Universitetssjukhuset - Onkologi Stockholm, Sweden.

View Article

Download full-text PDF

Source
February 2017

Reply to A.Y. Lin.

J Clin Oncol 2017 01 31;35(1):121-122. Epub 2016 Oct 31.

Antroula Papakonstantinou, Theodoros Foukakis, Kenny A. Rodriguez-Wallberg, and Jonas Bergh, Karolinska Institutet and University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.69.5866
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.69.5866DOI Listing
January 2017

Global Curriculum Edition 2016: European Society for Medical Oncology/American Society of Clinical Oncology Recommendations for Training in Medical Oncology.

J Clin Oncol 2017 01 31;35(2):254-255. Epub 2016 Oct 31.

Christian Dittrich, Kaiser Franz Josef-Spital, and Applied Cancer Research-Institution for Translational Research, Vienna, Austria; Michael P. Kosty, Scripps Clinic, La Jolla, CA; Svetlana Jezdic, European Society for Medical Oncology, Lugano, Switzerland; Doug Pyle, American Society of Clinical Oncology, Alexandria, VA; Rossana Berardi, Azienda Ospedaliero-Universitaria Ospedali Riuniti Università Politecnica delle Marche, Ancona, Italy; Jonas Bergh, Radiumhemmet, Karolinska Institutet and University Hospital, Stockholm, Sweden; Nagi S. El-Saghir, NK Basile Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon; Jean-Pierre Lotz, Assistance Publique-Hopitaux de Paris, Tenon Hospital, Institut Universitaire de Cancerologie-Universite Pierre et Marie Curie, Sorbonne University, Paris, France; Pia Österlund, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland; Nicholas Pavlidis, University of Ioannina, Ioannina, Greece; and Gunta Purkalne, Pauls Stradins Clinical University Hospital, Riga, Latvia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.2431DOI Listing
January 2017

High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer.

J Pathol Clin Res 2017 Jan 14;3(1):38-43. Epub 2016 Sep 14.

Department of Oncology-Pathology Cancer Center Karolinska, Karolinska Institutet Stockholm Sweden.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cjp2.56
Publisher Site
http://dx.doi.org/10.1002/cjp2.56DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259559PMC
January 2017

MICADo - Looking for Mutations in Targeted PacBio Cancer Data: An Alignment-Free Method.

Front Genet 2016 8;7:214. Epub 2016 Dec 8.

Centre de BioInformatique de Bordeaux, University of BordeauxBordeaux, France; Laboratoire Bordelais de Recherche en Informatique, Centre National de la Recherche Scientifique, University of BordeauxBordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fgene.2016.00214DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143680PMC
December 2016

Long-term outcome in young women with breast cancer: a population-based study.

Breast Cancer Res Treat 2016 11 13;160(1):131-143. Epub 2016 Sep 13.

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3983-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050247PMC
November 2016

Chemotherapy, Genetic Susceptibility, and Risk of Venous Thromboembolism in Breast Cancer Patients.

Clin Cancer Res 2016 Nov;22(21):5249-5255

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-1110DOI Listing
November 2016

ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016.

Authors:
Christian Dittrich Michael Kosty Svetlana Jezdic Doug Pyle Rossana Berardi Jonas Bergh Nagi El-Saghir Jean-Pierre Lotz Pia Österlund Nicholas Pavlidis Gunta Purkalne Ahmad Awada Susana Banerjee Smita Bhatia Jan Bogaerts Jan Buckner Fatima Cardoso Paolo Casali Edward Chu Julia Lee Close Bertrand Coiffier Roisin Connolly Sarah Coupland Luigi De Petris Maria De Santis Elisabeth G E de Vries Don S Dizon Jennifer Duff Linda R Duska Alexandru Eniu Marc Ernstoff Enriqueta Felip Martin F Fey Jill Gilbert Nicolas Girard Andor W J M Glaudemans Priya K Gopalan Axel Grothey Stephen M Hahn Diana Hanna Christian Herold Jørn Herrstedt Krisztian Homicsko Dennie V Jones Lorenz Jost Ulrich Keilholz Saad Khan Alexander Kiss Claus-Henning Köhne Rainer Kunstfeld Heinz-Josef Lenz Stuart Lichtman Lisa Licitra Thomas Lion Saskia Litière Lifang Liu Patrick J Loehrer Merry Jennifer Markham Ben Markman Marius Mayerhoefer Johannes G Meran Olivier Michielin Elizabeth Charlotte Moser Giannis Mountzios Timothy Moynihan Torsten Nielsen Yuichiro Ohe Kjell Öberg Antonio Palumbo Fedro Alessandro Peccatori Michael Pfeilstöcker Chandrajit Raut Scot C Remick Mark Robson Piotr Rutkowski Roberto Salgado Lidia Schapira Eva Schernhammer Martin Schlumberger Hans-Joachim Schmoll Lowell Schnipper Cristiana Sessa Charles L Shapiro Julie Steele Cora N Sternberg Friedrich Stiefel Florian Strasser Roger Stupp Richard Sullivan Josep Tabernero Luzia Travado Marcel Verheij Emile Voest Everett Vokes Jamie Von Roenn Jeffrey S Weber Hans Wildiers Yosef Yarden

ESMO Open 2016 29;1(5):e000097. Epub 2016 Sep 29.

Department of General Medical Oncology , University Hospitals Leuven , Leuven , Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2016-000097DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070299PMC
September 2016

Infection-related hospitalizations in breast cancer patients: Risk and impact on prognosis.

J Infect 2016 06 8;72(6):650-658. Epub 2016 Apr 8.

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jinf.2016.04.003DOI Listing
June 2016

Is Estradiol Monitoring Necessary in Women Receiving Ovarian Suppression for Breast Cancer?

J Clin Oncol 2016 05 7;34(14):1573-9. Epub 2016 Mar 7.

Karolinska Institutet and University Hospital, Stockholm, Sweden

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.3493DOI Listing
May 2016

Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer.

Br J Cancer 2016 05 26;114(10):1117-24. Epub 2016 Apr 26.

Department of Oncology-Pathology, Cancer Center Karolinska (CCK), Karolinska Institutet, 171 76 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2016.104DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865967PMC
May 2016

Intrinsic subtypes and genomic signatures of primary breast cancer and prognosis after systemic relapse.

Mol Oncol 2016 Apr 18;10(4):517-25. Epub 2015 Nov 18.

Department of Oncology and Pathology, Karolinska Institute and University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1016/j.molonc.2015.11.004
Publisher Site
http://dx.doi.org/10.1016/j.molonc.2015.11.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423143PMC
April 2016

Digital image analysis outperforms manual biomarker assessment in breast cancer.

Mod Pathol 2016 Apr 26;29(4):318-29. Epub 2016 Feb 26.

Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2016.34DOI Listing
April 2016

A 21-Gene Expression Assay in Breast Cancer.

N Engl J Med 2016 04;374(14):1386-7

Karolinska Institutet, Stockholm, Sweden

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1515988DOI Listing
April 2016

Sisyphean Efforts: Establishing the Correct Risk-Benefit Balance for Adjuvant Therapies.

J Clin Oncol 2016 Mar 19;34(9):895-7. Epub 2016 Jan 19.

University of Edinburgh Cancer Research Centre, Edinburgh, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.2255DOI Listing
March 2016

The ESMO/ASCO Global Curriculum and the evolution of medical oncology training in Europe.

ESMO Open 2016 18;1(1):e000004. Epub 2016 Jan 18.

Ludwig Boltzmann Institute for Applied Cancer Research (LBI-ACR VIEnna) and Applied Cancer Research-Institution for Translational Research Vienna (ACR-ITR VIEnna) Centre for Oncology and Haematology Kaiser Franz Josef-Spital , Vienna , Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2015-000004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070208PMC
January 2016

mTOR inhibitors counteract tamoxifen-induced activation of breast cancer stem cells.

Cancer Lett 2015 Oct 21;367(1):76-87. Epub 2015 Jul 21.

Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Department of Clinical Pathology/Cytology, Karolinska University Hospital, 17177 Stockholm, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2015.07.017DOI Listing
October 2015

Role of Tumor Pericytes in the Recruitment of Myeloid-Derived Suppressor Cells.

J Natl Cancer Inst 2015 Oct 21;107(10). Epub 2015 Aug 21.

Department of Medical Biochemistry and Biophysics, Division of Vascular Biology, Karolinska Institute, Stockholm, Sweden (JWH, TL, ML, YGI, HQ, MZ, MZA, IN, PR, GG); Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska University Hospital, Solna, Sweden (NPT, JP, JH, AÖ, JB); Department of Cell and Molecular Biology, Karolinska Institute, Stockholm, Sweden (HR, RSJ); Department of Physiology, Development, and Neuroscience, University of Cambridge, Cambridge, UK (RSJ); Department of Molecular Medicine and Surgery, Urology Laboratory, Karolinska Institute, Stockholm, Sweden (MP); Department of Urology, Karolinska University Hospital, Solna, Sweden (MP).Current affiliation: Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland (HQ).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv209DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592827PMC
October 2015

Highly reproducible results of breast cancer biomarkers when analysed in accordance with national guidelines - a Swedish survey with central re-assessment.

Acta Oncol 2015 Jul 11;54(7):1040-8. Epub 2015 May 11.

Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University , Lund , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2015.1037012DOI Listing
July 2015

Endothelial ALK1 Is a Therapeutic Target to Block Metastatic Dissemination of Breast Cancer.

Cancer Res 2015 Jun;75(12):2445-56

Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden. Division of Translational Cancer Research, Department of Laboratory Medicine, Medicon Village, Lund University, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-3706DOI Listing
June 2015